Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
46.51
+0.23 (0.50%)
At close: Jan 16, 2026, 4:00 PM EST
46.21
-0.30 (-0.65%)
Pre-market: Jan 20, 2026, 4:23 AM EST
Vera Therapeutics Market Cap
Vera Therapeutics has a market cap or net worth of $3.3 billion as of January 20, 2026. Its market cap has increased by 23.29% in one year.
Market Cap
3.30B
Enterprise Value
2.88B
1-Year Change
23.29%
Ranking
Category
Stock Price
$46.51
Market Cap Chart
Since the IPO on May 14, 2021, Vera Therapeutics's market cap has increased from $225.27M to $3.30B, an increase of 1,365.60%. That is a compound annual growth rate of 77.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 3.30B | -8.16% |
| Dec 31, 2025 | 3.59B | 34.24% |
| Dec 31, 2024 | 2.68B | 291.87% |
| Dec 29, 2023 | 683.38M | 27.69% |
| Dec 30, 2022 | 535.18M | -5.87% |
| Dec 31, 2021 | 568.54M | 152.38% |
| May 14, 2021 | 225.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |